News from our partners

cover

Schroders: Why the Covid-19 crisis is different for private assets

Looking for lessons in the past can be valuable, but Covid...

UBS AM: Seizing opportunities in the current market environment

The COVID-19 pandemic and associated lockdowns are causing...

cover

Schroders: How has coronavirus impacted the energy transition?

The spread of Covid-19 is affecting all walks of life and...

Volatilité

Capital Group: Marchés boursiers - et maintenant ?

Les fluctuations sauvages des marchés boursiers résultant de...

UBS AM: ‘Chinese government bonds are becoming a safe haven’

Investors look for diversification and low volatility and...

cover

Schroders: Are credit markets ready to shift gears?

The credit market sell-off has been indiscriminate so far...

UBS AM: The next steps for bond investors in the new world

UBS AM: The next steps for bond investors in the new world

Which four steps can bond investors take now to reflect the...

Quelle attitude pour son épargne face à la crise du Covid-19 ?

AXA IM : Quelle attitude pour son épargne face à la crise du Covid-19 ?

Dans une situation aussi inédite qu’imprévisible, les...

UBS AM: What is the potential impact of COVID-19 on global infrastructure markets?

Of most relevance to infrastructure investors is the likely...

UBS AM: The only real ‘bazooka’ is a COVID-19 vaccine

For the time being, the overwhelming monetary and fiscal...

Peter Hughes, PhD, Fund Manager, Healthcare Strategies at AXA IM

AXA IM: Is a vaccine for coronavirus on its way, and what are the challenges?

Peter Hughes, PhD, Fund Manager, Healthcare Strategies at...

cover

Schroders: How microfinance investment can empower female entrepreneurs?

BlueOrchard Chief Executive, Patrick Scheurle, explains why...

Our partners

Capital Group

Invesco

Morningstar

Nordea Asset Management

RBC BlueBay Asset Management

Schroders